Who funds this research? Most would say it's government, but they'd be wrong. ACSH friend Dr. Robert Popovian, vice president of Pfizer's U.S. Government Relations, discusses this perennially controversial topic.
Inclusivity for those with chronic disease or differing abilities is gaining momentum as a fashion trend. These targeted solutions to quality-of-life issues are a refreshing way to achieve the larger goal of a healthier society.
A new study published in JAMA details the U.S. county-level trends in mortality rates for major causes of death. While a bit flawed, it's a step in the right direction as regional health disparity is often way more vital to informing policy than national tendencies.
Is medicine ready for an Uber-style revolution to fill the void between what patients want and the type of healthcare services that are available?